Nevro Corp. is a medical device company which focuses on providing products for the patients suffering from chronic pain. It develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Company sells its products through its direct sales force, and a network of sales agents and independent distributors.

Employee Rating

4.3More
TypePublic
HQRedwood City, US
Founded2006
Size (employees)518 (est)
Websitenevro.com
Nevro Corp. was founded in 2006 and is headquartered in Redwood City, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Nevro Corp.

Rami Elghandour

Rami Elghandour

President and CEO
Andrew Galligan

Andrew Galligan

CFO
David Caraway

David Caraway

Chief Medical Officer
Doug Alleavitch

Doug Alleavitch

Vice President, Quality
Richard B. Carter

Richard B. Carter

Vice President, Finance, Corporate Controller
Christofer Christoforou

Christofer Christoforou

Vice President, Research and Development
Show more

Nevro Corp. Office Locations

Nevro Corp. has an office in Redwood City
Redwood City, (HQ)
1800 Bridge Parkway
Show all (1)
Report incorrect company information

Nevro Corp. Financials and Metrics

Nevro Corp. Revenue

Embed Graph
View revenue for all periods
Nevro Corp.'s revenue was reported to be $326.67 m in FY, 2017
USD

Revenue (Q3, 2018)

95.6m

Gross profit (Q3, 2018)

67.2m

Gross profit margin (Q3, 2018), %

70.3%

Net income (Q3, 2018)

(11.3m)

EBIT (Q3, 2018)

(9.2m)

Market capitalization (12-Dec-2018)

1.3b

Closing stock price (12-Dec-2018)

41.7

Cash (30-Sep-2018)

21.4m

EV

1.4b
Nevro Corp.'s current market capitalization is $1.3 b.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Revenue

32.6m69.6m228.5m326.7m

Revenue growth, %

114%228%

Cost of goods sold

11.3m28.1m75.4m99.0m

Gross profit

21.3m41.5m153.1m227.7m
Quarterly
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

8.7m9.7m11.4m15.4m41.7m55.4m60.9m68.4m78.0m82.3m87.6m96.1m95.6m

Cost of goods sold

2.7m3.9m5.5m6.0m15.7m18.8m19.2m22.1m24.1m24.3m25.6m28.2m28.4m

Gross profit

5.9m5.8m5.9m9.4m26.0m36.6m41.7m46.4m53.9m57.9m62.0m67.9m67.2m

Gross profit Margin, %

68%60%52%61%62%66%68%68%69%70%71%71%70%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

25.3m87.0m41.4m42.8m

Accounts Receivable

22.5m52.8m

Inventories

62.4m85.2m98.1m

Current Assets

201.1m282.6m420.3m441.2m
Quarterly
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(30.7m)(67.4m)(31.8m)(36.7m)

Depreciation and Amortization

96.0k614.0k1.7m2.5m

Inventories

(5.5m)(49.4m)(27.0m)(16.3m)

Accounts Payable

1.3m17.1m(5.6m)2.2m
Quarterly
USDY, 2018

EV/EBIT

-150 x

EV/CFO

-129.4 x

Debt/Equity

0.6 x

Debt/Assets

0.3 x

Financial Leverage

1.8 x
Show all financial metrics

Nevro Corp. Operating Metrics

FY, 2016

Patents Issued

132

Patents Pending

101

Trademarks

16
Show all operating metrics
Report incorrect company information

Nevro Corp. Online and Social Media Presence

Embed Graph
Report incorrect company information

Nevro Corp. News and Updates

Lifshitz & Miller LLP Announces Investigation of Corium International, Inc., Dragon Victory International Limited, Honeywell International Inc., Hortonworks, Inc., Idaho Independent Bank, L3 Technologies, Inc., MBT Financial Corp., Nevro Corp., and Ormat Technologies, Inc.

NEW YORK, Nov. 1, 2018 /PRNewswire/ -- Corium International, Inc. (CORI) Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the sale of CORI to Gurnet Point Capital for $12.50 per share. If you are a Corium investor, and would like...

NEVRO HOLDINGS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Nevro Corp. - NVRO

NEW ORLEANS, Sept. 21, 2018 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 22, 2018 to file lead plaintiff applications in a securities class action lawsuit against Nevro Corp. (NYSE: NVRO), if they purchased the...

NEVRO SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Nevro Corp. - NVRO

NEW ORLEANS, Aug. 31, 2018 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 22, 2018 to file lead plaintiff applications in a securities class action lawsuit against...
Report incorrect company information

Nevro Corp. Company Life and Culture

Report incorrect company information

Nevro Corp. Frequently Asked Questions

  • When was Nevro Corp. founded?

    Nevro Corp. was founded in 2006.

  • Who are Nevro Corp. key executives?

    Nevro Corp.'s key executives are Rami Elghandour, Andrew Galligan and David Caraway.

  • How many employees does Nevro Corp. have?

    Nevro Corp. has 518 employees.

  • What is Nevro Corp. revenue?

    Latest Nevro Corp. annual revenue is $326.7 m.

  • What is Nevro Corp. revenue per employee?

    Latest Nevro Corp. revenue per employee is $630.6 k.

  • Who are Nevro Corp. competitors?

    Competitors of Nevro Corp. include NeuSpera Medical, Relievant Medsystems and AqueSys.

  • Where is Nevro Corp. headquarters?

    Nevro Corp. headquarters is located at 1800 Bridge Parkway , Redwood City.

  • Where are Nevro Corp. offices?

    Nevro Corp. has an office in Redwood City.

  • How many offices does Nevro Corp. have?

    Nevro Corp. has 1 office.